Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastrointestinal lymphoma.

C R Thomas1, R Share

  • 1Department of Internal Medicine, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.

Medical and Pediatric Oncology
|January 11, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advocating for a "Community to bench model" in the 21st century.

EBioMedicine·2020
Same author

High-flow nasal therapy - modelling the mechanism.

Anaesthesia·2019
Same author

Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2015
Same author

New methodology, tools, and protocolized analysis are needed to advance individualized treatment paradigms in esophageal cancer.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2014
Same author

Margin width is not predictive of residual disease on re-excision in breast conserving therapy.

Journal of surgical oncology·2013
Same journal

Kaposiform hemangioendothelioma and therapy with interferon-alpha.

Medical and pediatric oncology·2003
Same journal

Importance of informed consent in offering to return research results to research participants.

Medical and pediatric oncology·2003
Same journal

Tumor lysis syndrome and neuroblastoma.

Medical and pediatric oncology·2003
Same journal

High incidence of brain tumors of childhood in Hungary between 1989 and 2001.

Medical and pediatric oncology·2003
Same journal

Surviving childhood cancer: what next? Issues under consideration at the After Completion of Therapy (ACT) clinic in India.

Medical and pediatric oncology·2003
Same journal

Local control in childhood extremity sarcomas: salvaging limbs and sparing function.

Medical and pediatric oncology·2003
See all related articles

Primary gastrointestinal (GI) lymphoma requires careful diagnosis and staging. Surgical resection, followed by adjuvant therapies for advanced cases, offers the best chance for cure in this rare condition.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Primary gastrointestinal (GI) lymphoma is a rare malignancy.
  • Distinguishing it from nodal lymphoma is crucial.
  • Clinical presentation can be non-specific, with less common B symptoms.

Observation:

  • Diagnosis often requires transmural biopsy, revealing high-grade morphology.
  • Staging includes bone marrow examination; formal staging laparotomy is not always necessary.
  • Prognosis varies with disease stage, with earlier stages (Mushoff IE, IIE1) faring better.

Findings:

  • Surgical resection with clear margins is essential for curative intent.
  • Adjuvant chemotherapy or radiotherapy can improve survival in selected early-stage disease.

Related Experiment Videos

  • Chemotherapy post-debulking surgery is recommended for advanced stages to prevent complications.

    • Implications:

    • Optimal management involves a multidisciplinary approach combining surgery, chemotherapy, and radiotherapy.
    • Further multi-institutional trials are needed to refine treatment strategies.
    • Accurate staging and timely intervention are key to improving patient outcomes in primary GI lymphoma.